N-(3,3-二甲基吲哚啉-6-基)-2-((吡啶-4-基甲基)氨基)烟酰胺

英文名： N-(3,3-Dimethylindolin-6-yl)-2-((pyridin-4-ylmethyl)amino)nicotinamide

别名：莫特塞尼;N-(2,3-二氢-3,3-二甲基-1H-吲哚-6-基)-2-[(4-吡啶甲基)氨基]-3-吡啶甲酰胺;莫替沙尼;N-(3,3-二甲基吲哚啉-6-基)-2-(吡啶-4-基甲氨基)烟酰胺;3-吡啶甲酰胺,N-(2,3-二氢-3,3-二甲基-1H-吲哚-6-基)-2-[(4-吡啶基甲基)氨基] 莫特塞尼;N-(2,3-二氢-3,3-二甲基-1H-吲哚-6-基)-2-[(4-吡啶甲基)氨基]-3-吡啶甲酰胺;莫替沙尼;N-(3,3-二甲基吲哚啉-6-基)-2-(吡啶-4-基甲氨基)烟酰胺;3-吡啶甲酰胺,N-(2,3-二氢-3,3-二甲基-1H-吲哚-6-基)-2-[(4-吡啶基甲基)氨基] 展开

CAS No. : 453562-69-1

分子式 : C₂₂H₂₃N₅O

分子量 : 373.46

大包装询价? 收藏产品

中文名称	N-(3,3-二甲基吲哚啉-6-基)-2-((吡啶-4-基甲基)氨基)烟酰胺
中文别名	莫特塞尼;N-(2,3-二氢-3,3-二甲基-1H-吲哚-6-基)-2-[(4-吡啶甲基)氨基]-3-吡啶甲酰胺;莫替沙尼;N-(3,3-二甲基吲哚啉-6-基)-2-(吡啶-4-基甲氨基)烟酰胺;3-吡啶甲酰胺,N-(2,3-二氢-3,3-二甲基-1H-吲哚-6-基)-2-[(4-吡啶基甲基)氨基]
英文名称	N-(3,3-Dimethylindolin-6-yl)-2-((pyridin-4-ylmethyl)amino)nicotinamide
英文别名	Motesanib;N-(2,3-Dihydro-3,3-dimethyl-1H-indol-6-yl)-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide;Motesanib (AMG-706);Motesanib(AMG706);N-(3,3-dimethylindolin-6-yl)-2-(pyridin-4-ylmethylamino)nicotinamide;AMG 706;AMG-706;Motesanib Base;453562-69-1;SB14621;AMG706/ Motesanib;N-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)-3-pyridinecarboxamide;N-(3,3-dimethylindolin-6-yl)-2-((pyridin-4-ylmethyl)amino)nicotinamide;MFCD10567689;HY-10228;Q6917202;N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-((4-pyridinylmethyl)amino)-3-pyridinecarboxamide;NSC800801;HMS3265G20;N-(3,3-DIMETHYL-2,3-DIHYDRO-1H-INDOL-6-YL)-2-((PYRIDIN-4-YLMETHYL)AMINO)NICOTINAMIDE;Motesanib [USAN];NSC-800801;HMS3244A09;N-(3,3-dimethyl-2,3-dihydro-1H-indol-6-yl)-2-[(pyridin-4- ylmethyl)amino]pyridine-3-carboxamide;s5793;DB05575;3-Pyridinecarboxamide, N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-((4-pyridinylmethyl)amino)-;Motesanib [USAN:INN];cid_11667893;BCP9000289;HMS3244A10;NCGC00263205-06;AMG706;CHEMBL572881;NS00071589;MOTESANIB [MART.];DTXSID10196488;HMS3265H20;FT-0706483;HMS3265G19;BRD-K99616396-316-01-2;SCHEMBL187470;MOTESANIB [WHO-DD];AKOS005146333;MOTESANIB [MI];EX-8571;AS-16212;BDBM24773;U1JK633AYI;A19395;D06678;MOTESANIB [INN];GTPL5660;BCP01982;CHEBI:51098;UNII-U1JK633AYI;N-(3,3-dimethylindolin-6-yl)-2-(4-pyridylmethylamino)nicotinamide;N-(3,3-dimethyl-2,3-dihydro-1H-indol-6-yl)-2-[(pyridin-4-ylmethyl)amino]pyridine-3-carboxamide;EX-A487;NSC-760843;N-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide;HMS3265H19;PA-11667893;NSC760843;AC-32664;N-(3,3-Dimethyl-2,3-dihydro-1H-indol-6-yl)-2-((pyridin-4-ylmethyl)amino)pyridine-3-carboxamide;NCGC00263205-01;J-522983;BCPP000407;Motesanib (USAN);453562-69-1 (free base);HMS3244B09;BRD-K99616396-316-04-6;BRD-K99616396-001-05-1;motesanibum;BRD-K99616396-316-05-3;Motesanib?;BRD-K99616396-316-06-1;DTXCID20118979;MOTESANIB (MART.);SDCCGSBI-0654329.P001
CAS No.	453562-69-1
分子式	C₂₂H₂₃N₅O
分子量	373.46